CHE vs PATH
Chemed Corp (CHE) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CHE and PATH stock pages for the full models.
Not investment advice.